Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

[Preparation and Characterization of a Novel Functional Anti-Human CD83 Monoclonal Antibody].

Preparation and characterization of a novel monoclonal antibody against human PD-1

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

[Preparation of a Novel Functional Anti-Human CD40 Monoclonal Antibody and Identification of Its Bioactivity].

Two novel monoclonal antibodies produced against human CD83 molecule.

Preparation of a Novel Functional Mouse Anti-Human 2Igb7-H3 Antibody and Primary Study of Its Biological Characteristics.

Preparation and Characterization of a Novel Monoclonal Antibody Against Human PD-L2 (B7-DC)

Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.

Development of a Novel Functional Monoclonal Antibody to Human CD275: Characterization and Biological Activity.

[Preparation and Characterization of Three Novel Monoclonal Antibodies Against Human PD-L1].

Preparation of anti-human 4-1BB monoclonal antibody and characterization of its biological activities]

[Preparation and Characterization of a Mouse Anti-Human CD40 Mutant Monoclonal Antibody].

[Preparation and Characterization of Two Novel Functional Monoclonal Antibodies Against Human OX40L].

Preparation of a functional monoclonal antibody against human 4-1BBL molecule and analysis of its biological characteristics

[Preparation and Characterization of a Directly Labeled Mouse Anti-Human CD14 Monoclonal Antibody ZCH-2F9-FITC].

Preparation of Anti-Human 4-1BB Monoclonal Antibody and Analysis of Its Biological Functions

Construction, Expression, and Characterization of a Novel Human-Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage Leukemias.

Preparation of a Monoclonal Antibody Against Human 41Gb7-H3 Molecule and Analysis of Its Biological Characteristics

Preparation of Functional Monoclonal Antibody Against Human CD28 and Analysis of Its Biological Feature

Preparation of Anti-Human CD28 Functional Monoclonal Antibody and Characterization of Its Biological Activities

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].